Publication:
The Thai version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)

dc.contributor.authorSoamarat Vilaiyuken_US
dc.contributor.authorSirisucha Soponkanapornen_US
dc.contributor.authorButsabong Lerkvaleekulen_US
dc.contributor.authorTapanee Pipatkullacharten_US
dc.contributor.authorDara Mairiangen_US
dc.contributor.authorAlessandro Consolaroen_US
dc.contributor.authorFrancesca Bovisen_US
dc.contributor.authorNicolino Rupertoen_US
dc.contributor.otherUniversità degli Studi di Genovaen_US
dc.contributor.otherIRCCS Istituto Giannina Gaslini - Ospedale Pediatricoen_US
dc.contributor.otherFaculty of Medicine, Ramathibodi Hospital, Mahidol Universityen_US
dc.date.accessioned2019-08-23T11:21:38Z
dc.date.available2019-08-23T11:21:38Z
dc.date.issued2018-04-01en_US
dc.description.abstract© 2018, The Author(s). The Juvenile Arthritis Multidimensional Assessment Report (JAMAR) is a new parent/patient-reported outcome measure that enables a thorough assessment of the disease status in children with juvenile idiopathic arthritis (JIA). We report the results of the cross-cultural adaptation and validation of the parent and patient versions of the JAMAR in the Thai language. The reading comprehension of the questionnaire was tested in ten JIA parents and patients. Each participating centre was asked to collect demographic, clinical data and the JAMAR in 100 consecutive JIA patients or all consecutive patients seen in a 6-month period and to administer the JAMAR to 100 healthy children and their parents. The statistical validation phase explored descriptive statistics and the psychometric issues of the JAMAR: the three Likert assumptions, floor/ceiling effects, internal consistency, Cronbach’s alpha, interscale correlations, test–retest reliability, and construct validity (convergent and discriminant validity). A total of 104 JIA patients (45.2% systemic JIA, 10.6% oligoarticular, 9.6% RF negative polyarthritis, 34.6% other categories) and 102 healthy children, were enrolled in one paediatric rheumatology centre. Notably, none of the enrolled JIA patients is affected with psoriatic arthritis or undifferentiated arthritis. The JAMAR components discriminated well healthy subjects from JIA patients. All JAMAR components revealed satisfactory psychometric performances. In conclusion, the Thai version of the JAMAR is a valid tool for the assessment of children with JIA and is suitable for use both in routine clinical practice and clinical research.en_US
dc.identifier.citationRheumatology International. Vol.38, (2018), 387-393en_US
dc.identifier.doi10.1007/s00296-018-3977-5en_US
dc.identifier.issn1437160Xen_US
dc.identifier.issn01728172en_US
dc.identifier.other2-s2.0-85045278440en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/46031
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85045278440&origin=inwarden_US
dc.subjectImmunology and Microbiologyen_US
dc.subjectMedicineen_US
dc.titleThe Thai version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)en_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85045278440&origin=inwarden_US

Files

Collections